Research Leaders Across New York State Form Empire State Cellular Therapy Consortium - Takeaways - MDSpire

Research Leaders Across New York State Form Empire State Cellular Therapy Consortium

To expand on early progress in the emerging field of cell and gene therapy, five research centers across New York State are collaborating to develop new cell therapies for cancer and other diseases.

  • By

  • July 29, 2025

  • 7 min

Share

  • 1

    Five research centers in New York State have formed the Empire State Cellular Therapy Consortium to advance cell and gene therapies.

  • 2

    The consortium aims to enhance access to innovative cancer treatments and expand clinical trials across its member institutions.

  • 3

    Cell and gene therapies have shown significant success in treating blood cancers and are being explored for solid tumors and other diseases.

  • 4

    The consortium will facilitate collaboration among researchers, improving efficiency and accelerating the development of new therapies.

  • 5

    Roswell Park's GMP Engineering & Cell Manufacturing Facility will serve as a key resource for consortium members in therapy development.

Original Source(s)

Research Leaders Across New York State Form Empire State Cellular Therapy Consortium

  • by

  • July 29, 2025

Related Content

This Week’s CGT News: Novo’s Parkinson’s Pivot

Novo Nordisk’s Parkinson’s cell therapy finds a new home at Cellular Intelligence, while base editing, prime editing, and large-insertion genome writing push forward

  • May 18, 2026

  • 7 min
Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma